NKE Stock Analysis: Nike | NYSE
Footwear & Accessories | NYSE, USA | Market Cap: 52.679m USD | 12M Return: -46.7% | US6541061031 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.16B
EPS Trend: -89.0%
Qual. Beats: 4
Rev. Trend: -94.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NIKE, Inc. is a global designer, developer, and marketer of athletic footwear, apparel, equipment, and accessories, serving men, women, and kids across North America, Europe, the Middle East, Africa, Greater China, Asia Pacific, and Latin America. The company operates a multi-brand portfolio, selling products under trademarks such as NIKE, Jordan, Converse, Jumpman, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell, which is a common approach in the consumer discretionary footwear sector to reach distinct consumer segments and price points.
The company sells through both wholesale channels-footwear stores, sporting goods stores, athletic specialty stores, department stores, and other retailers-and directly to consumers through NIKE Direct retail stores and digital platforms. It also licenses apparel featuring college and professional team and league logos, and offers complementary consumer services including fitness apps, sports content, and digital features in retail stores.
Originally founded in 1964 as Blue Ribbon Sports, the company was renamed NIKE, Inc. in May 1971 and is headquartered in Beaverton, Oregon. The business combines product sales, licensing, and digital/experiential services to reinforce its brand-led model typical of large-cap athletic footwear and apparel companies.
- Greater China revenue decline persists amid domestic brand competition
- Direct-to-consumer margins compress on heavier promotional activity
- Running footwear gains market share against On and Hoka rivals
| Net Income: 3.11b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.25 > 1.0 |
| NWC/Revenue: 25.98% < 20% (prev 27.63%; Δ -1.65% < -1%) |
| CFO/TA 0.07 > 3% & CFO 2.87b > Net Income 3.11b |
| Net Debt (5.10b) to EBITDA (4.70b): 1.09 < 3 |
| Current Ratio: 1.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.48b) vs 12m ago 0.35% < -2% |
| Gross Margin: 42.91% > 18% (prev 42.73%; Δ 0.18% > 0.5%) |
| Asset Turnover: 123.7% > 50% (prev 126.6%; Δ -2.85% > 0%) |
| Interest Coverage Ratio: 14.13 > 6 (EBIT TTM 3.90b / Interest Expense TTM 276.0m) |
| A: 0.31 (Total Current Assets 24.6b - Total Current Liabilities 12.5b) / Total Assets 38.4b |
| B: -0.00 (Retained Earnings -155.0m / Total Assets 38.4b) |
| C: 0.10 (EBIT TTM 3.90b / Avg Total Assets 37.5b) |
| D: 0.63 (Book Value of Equity 14.9b / Total Liabilities 23.5b) |
| Altman-Z'' = 3.41 = A |
| DSRI: 1.25 (Receivables 5.93b/4.72b, Revenue 46.4b/46.3b) |
| GMI: 1.00 (GM 42.73% / 42.91%) |
| AQI: 1.04 (AQ_t 0.16 / AQ_t-1 0.16) |
| SGI: 1.00 (Revenue 46.4b / 46.3b) |
| TATA: 0.01 (NI 3.11b - CFO 2.87b) / TA 38.4b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of September 28, 2026, the stock is trading at USD 35.75 with a total of 38,105,838 shares traded. Over the past week, the price has changed by +0.68%, over one month by -8.49%, over three months by -11.66% and over the past year by -46.67%.
Current recommended Stop Loss: 34.60 (which is 3.2% or 1.2 ATR below the current price).
Nike has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold NKE.
- StrongBuy: 14
- Buy: 2
- Hold: 20
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 48.2 | 34.9% |
P/E Trailing = 16.9095
P/E Forward = 21.1416
P/S = 1.1354
P/B = 3.6287
P/EG = 1.4093
Revenue TTM = 46.4b USD
EBIT TTM = 3.90b USD
EBITDA TTM = 4.70b USD
Long Term Debt = 5.94b USD (from longTermDebt, last quarter)
Short Term Debt = 2.48b USD (from shortTermDebt, last quarter)
Debt = 14.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 3.09b
Net Debt = 5.10b USD (calculated: Debt 14.1b - CCE 9.03b)
Enterprise Value = 57.8b USD (52.7b + Debt 14.1b - CCE 9.03b)
Interest Coverage Ratio = 14.13 (Ebit TTM 3.90b / Interest Expense TTM 276.0m)
EV/FCF = 26.45x (Enterprise Value 57.8b / FCF TTM 2.18b)
FCF Yield = 3.78% (FCF TTM 2.18b / Enterprise Value 57.8b)
FCF Margin = 4.71% (FCF TTM 2.18b / Revenue TTM 46.4b)
Net Margin = 6.70% (Net Income TTM 3.11b / Revenue TTM 46.4b)
Gross Margin = 42.91% ((Revenue TTM 46.4b - Cost of Revenue TTM 26.5b) / Revenue TTM)
Gross Margin QoQ = 49.15% (prev 40.16%)
Tobins Q-Ratio = 1.50 (Enterprise Value 57.8b / Total Assets 38.4b)
Interest Expense / Debt = 1.95% (Interest Expense 276.0m / Debt 14.1b)
Taxrate = 20.31% (792.0m / 3.90b)
NOPAT = 3.11b (EBIT 3.90b * (1 - 20.31%))
Current Ratio = 1.96 (Total Current Assets 24.6b / Total Current Liabilities 12.5b)
Debt / Equity = 0.95 (Debt 14.1b / totalStockholderEquity, last quarter 14.9b)
Debt / EBITDA = 1.09 (Net Debt 5.10b / EBITDA 4.70b)
Debt / FCF = 2.33 (Net Debt 5.10b / FCF TTM 2.18b)
Total Stockholder Equity = 14.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.29% (Net Income 3.11b / Total Assets 38.4b)
RoE = 22.00% (Net Income TTM 3.11b / Total Stockholder Equity 14.1b)
RoCE = 19.43% (EBIT 3.90b / Capital Employed (Equity 14.1b + L.T.Debt 5.94b))
RoIC = 11.94% (NOPAT 3.11b / Invested Capital 26.0b)
WACC = 7.10% (E(52.7b)/V(66.8b) * Re(8.59%) + D(14.1b)/V(66.8b) * Rd(1.95%) * (1-Tc(0.20)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.07 | Cagr: -1.28%
[DCF] Terminal Value 73.10% ; FCFF base≈2.62b ; Y1≈2.30b ; Y5≈1.85b
[DCF] Fair Price = 20.52 (EV 29.8b - Net Debt 5.10b = Equity 24.7b / Shares 1.20b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -88.99 | EPS CAGR: -30.36% | SUE: 1.17 | # QB: 4
Revenue Correlation: -94.09 | Revenue CAGR: -4.84% | SUE: 0.41 | # QB: 0
EPS current Quarter (2026-08-31): EPS=0.45 | Chg30d=-1.65% | Revisions=+40% | Analysts=22
EPS next Quarter (2026-11-30): EPS=0.52 | Chg30d=-2.51% | Revisions=-40% | Analysts=22
EPS current Year (2027-05-31): EPS=1.69 | Chg30d=-1.73% | Revisions=-44% | GrowthEPS=-19.4% | GrowthRev=-1.9%
EPS next Year (2028-05-31): EPS=2.19 | Chg30d=-2.11% | Revisions=-44% | GrowthEPS=+29.2% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: -42% (up=4, down=12)